Living Well With Lymphoma

Lymphoma Clinical Trial

Official title: Living Well With Lymphoma: Improving Diet Quality to Improve Energy, Sleep and Quality of Life

Status Recruiting

Clinical Trial Summary

In this study the investigators are proposing to evaluate the efficacy, sustainability, and mechanisms of 3 months of individualized counseling of the FRD delivered by registered dietitians, over 8 sessions by phone/video conferencing on fatigue, quality of life, and associated symptoms in persistently fatigued lymphoma cancer survivors compared to 3 months of individualized counseling of the attention control (matched for time and frequency of interactions with the FRD) the General Health Curriculum (GHC). The investigators will randomize and follow 68 lymphoma cancer survivors; accounting for a ~10% drop out rate to achieve a target of 60 patients that will complete the study. The investigators hypothesize that persistently fatigued lymphoma cancer survivors will experience improvements in fatigue, quality of life, and symptoms commonly associated with fatigue, which are then maintained at 15-months post-enrollment; and decreased CRP and alterations in inflammation-associated DNA methylation consistent with reduced inflammation from following the FRD as compared to the GHC.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Lymphoma

• NCT number: NCT06047626
• Study type: Interventional
• Source: University of Michigan Rogel Cancer Center
• Contact: Sara Snyder
• Phone: 734-998-7124
• Email: fammed-szickstudy@med.umich.edu
• Status: Recruiting
• Phase: N/A
• Start date: March 7, 2024
• Completion date: September 2028